Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-04-26FDA Approved: CAPLYTA — Supplemental Application (Intra-Cellular Therapies, Inc)
The FDA approved a supplemental application for CAPLYTA (lumateperone) from Intra-Cellular Therapies, Inc. The approval expands the drug’s l…
-
FDA approval · 2022-04-26FDA Approved: QUETIAPINE — Original Application (Solco Healthcare U.S., LLC)
The FDA approved the original application for generic quetiapine from Solco Healthcare U.S., LLC.
-
FDA approval · 2022-04-14FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved an original ANDA for fluphenazine hydrochloride from Sun Pharmaceutical Industries, Inc., confirming a generic formulation.
-
FDA approval · 2022-04-05FDA Approved: IGALMI — Original Application (BioXcel Therapeutics, Inc.)
FDA approves IGALMI (dexmedetomidine) by BioXcel Therapeutics for the acute treatment of agitation in adults with schizophrenia or bipolar I…
-
FDA approval · 2022-04-01FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved a generic version of fluphenazine hydrochloride through an original ANDA submission by Upsher-Smith Laboratories, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-03-24FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA (paliperidone) from Janssen Pharmaceuticals, Inc. This action approves changes descri…
-
FDA approval · 2022-02-28FDA Approved: THIOTHIXENE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for thiothixene, a generic antipsychotic, submitted by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2022-01-28FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2022-01-13FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for lurasidone hydrochloride submitted by Accord Healthcare, Inc.
-
FDA approval · 2021-11-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved chlorpromazine hydrochloride from Chartwell RX, LLC under an original ANDA for generic use.
-
FDA approval · 2021-11-19FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Olanzapine from Macleods Pharmaceuticals Limited.
-
FDA approval · 2021-11-18FDA Approved: OLANZAPINE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for a generic olanzapine product from Upsher-Smith Laboratories, LLC (ANDA204319).
-
FDA approval · 2021-11-12FDA Approved: QUETIAPINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a generic quetiapine product (ANDA204203). This marks a supplemental ap…
-
FDA approval · 2021-11-12FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE submitted by Somerset Therapeutics, LLC.
-
FDA approval · 2021-11-10FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine from Mylan Pharmaceuticals Inc., expanding its approved labeling and indications.
-
FDA approval · 2021-11-10FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2021-11-10FDA Approved: CLOZAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s Supplemental Application for CLOZAPINE, a generic version of clozapine under ANDA 202873. The approval…
-
FDA approval · 2021-11-10FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for Clozapine (generic) under ANDA090308. This constitutes an approved supplemental modificatio…
-
FDA approval · 2021-11-10FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Clozapine from Aurobindo Pharma Limited, enabling a generic version to proceed.
-
FDA approval · 2021-11-10FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's supplemental application for Clozapine, allowing a generic version of Clozapine to be marketed.
-
FDA approval · 2021-11-09FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for quetiapine fumarate from Macleods Pharmaceuticals Limited, enabling a generic version of the…
-
FDA approval · 2021-11-03FDA Approved: OLANZAPINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for olanzapine from Aurobindo Pharma Limited under ANDA 203708, finalizing approval of a generic…
-
FDA approval · 2021-11-02FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for ZIPRASIDONE from Dr. Reddy's Laboratories Limited, indicating the approval of a generic version …
-
FDA approval · 2021-11-02FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Quetiapine Fumarate from Unichem Pharmaceuticals (USA), Inc. The action approves changes to the …
-
FDA approval · 2021-11-01FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic quetiapine fumarate product from Aurobindo Pharma Limited, enabling its use as a g…